PegInterferon - Preventing Hepatitis C -- January 1, 1999 -- American Family Physician

Preventing Hepatitis C -- January 1, 1999 -- American Family Physician
Please note: This information was as current as we could make it on the date given above. But medical information is always changing, and some information given here may be out of date. ... 4 million people in this country have hepatitis C. This handout will tell you what hepatitis C is and how you can ...

Hepatitis C - Learn more from MedlinePlus
Find the latest news stories, overviews, research and more on Hepatitis C from MedlinePlus, the National Library of Medicine's consumer health site.

Management of Hepatitis C
Management of Hepatitis C Management of Hepatitis C "The hepatitis C virus (HCV) is a major cause of both acute and chronic hepatitis in the United States. Hepatitis C, previously known as "non-A, non-B hepatitis," affects between 1 and 2 ...

Public Health Agency of Canada - Hepatitis C - Home
Public Health Agency of Canada's home to all of our hepatitis C information. ... A and B existed, but it was only in 1989 that the hepatitis C virus was first identified ... have no symptoms. The Hepatitis C Prevention, Support & Research Program intends to ...

Hepatitis Information Network: Hepatitis C
News, epidemiology, natural history, and notes on the management and treatment of the disease.

Interferon - Hepatitis C treatment developed in Cuba

Hepatitis C treatment developed in Cuba
radiojamaica.com, Jamaica - Mar 15, 2006Cuba says it has developed a treatment for the Hepatitis C virus that would contribute to a long-term cure of liver damage caused by the disease. ...

Kindness in the doctor's kit
Fort Wayne News Sentinel, IN - Apr 7, 2006... At age 26, Campbell had never been on the other side of the bad news scenario, so when he told a 20-year-old she had hepatitis C, he paused. ...

Schering-Plough and PTC ink hepatitis C deal
Pharmaceutical Business Review - Mar 21, 2006... entered into an exclusive collaboration and licensing agreement to develop PTC's preclinical compounds for the oral treatment of hepatitis C virus infection ...

Cuba develops anti-hepatitis C therapy
Dominican Today, Dominican Republic - Mar 15, 2006Havana. The Havana-based Center for Genetic Engineering and Biotechnology (CIGB) has come up with a treatment against the Hepatitis C virus that will ...

Hepatitis C Screening and Treatment Outcomes in Patients With ...
Psychosomatics (subscription) - Mar 10, 2006... Address correspondence and reprint requests to Dr. Rifai, Northwest Hepatitis C Research Center, Portland VA Medical Center and Oregon Health and Science Univ ...

Weekender Calendar
Fitchburg Sentinel, MA - Apr 6, 2006... 3163. Hepatitis C medical lecture: 5:30 pm, buffett; 6 to 8:30 pm program, Wednesday, May 3, Slattery's Restaurant, Fitchburg. North ...

PegInterferon - Hepatitis C Virus (HCV): Hep C Support

Hepatitis C Virus (HCV): Hep C Support
Learn More About Hepatitis C Virus (HCV) and Hep C Support Hear from patients about their experiences with hepatitis C. Learn more about hepatitis C

The Hepatitis C Council of NSW
Provides information, support and services in the Australian state of New South Wales. Includes state-wide telephone support service, internet forum and email information option.

Hepatitis Neighborhood
site providing information and support for those coping with infection by hepatitis C and other forms of viral and non-viral hepatitis. The website offers information about the disease of hepatitis C

Hepatitis c
HEPATITIS C What is hepatitis? Hepatitis is an inflammation of the liver caused by certain viruses and other factors, such as alcohol abuse, some medications and trauma.

HIV and Hepatitis.com - Internet Publication
The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for HIV, AIDS and chronic hepatitis B and hepatitis C [and offers a free subscription service

PegInterferon - Researchers look for hepatitis C vaccine

Researchers look for hepatitis C vaccine
News 14 Raleigh / Durham - (ST. LOUIS) - It's been called the silent epidemic. Four million Americans now live with it, and there's no cure. As many as 200 million people around the world have hepatitis C, and researchers expect that number to triple in the next decade. The

Millennium Biotechnologies Group Enters into Letter of Intent with
Genetic Engineering News - Millennium Biotechnologies Group, Inc. (MBTG) announced today that it has entered into a letter of intent with Aisling Capital II, LP which, if consummated, would result in the sale by Millennium's wholly owned subsidiary of all of the assets used in

Beleagured Travis County ME to retire
KVUE - The beleaguered Travis County medical examiner is retiring. Dr. Roberto Bayardo announced his decision just hours after a meeting with County Judge Sam Biscoe Thursday. The move comes amid mounting criticism about the way Bayardo's office is run. The

County Council to examine controversial needle exchange program
Pittsburgh Post-Gazette - Yesterday, more than 100 people walked through the parking lot of the Allegheny County Health Department, entered one of the building's narrow hallways, and got fresh supplies of the alcohol swabs, syringes and needles they need to inject illegal

Knockin' Down Threes
Motley Fool - The three-point shot can be a game-changer. If a team gets hot behind the arc, watch out. The points will start adding up fast. The power of the three-pointer This year's finalists, UCLA and Florida, are evenly matched teams. That's why their

Surge in home diagnostic kits provides doctor in a box
Seattle Post Intelligencer - For nearly four decades, women have used home tests to find out whether they are pregnant. Paul Joseph Brown / P-I Diagnostic kits stand to take up even more space on drugstore shelves as the number tests that can be done at home soars. More recently

Robber who used taxi gets ride to jail
Stuff - Twenty-one pages were required to list the previous convictions of Robert Le Brazier, 38, who admitted robbing the Westpac Bank in Palmerston North last year. Le Brazier, who was appearing in Palmerston North District Court yesterday for sentencing

PegInterferon - Viral Hepatitis

Viral Hepatitis
... viralh epatitis viral ehpatitis viral hpeatitis viral heaptitis viral heptaitis viral hepaittis viral hepattiis viral ...

[Primate] | [All the best Primate resources at foreclosure.informationhunting.com]
Links and information about Primate and subjects relating to Primate.

Hepatit
Hepatit i in S per Siteler Burada. ... ... wasting syndrome and Michigan rabbit viral heaptitis 2006 BlueCare and TennCare WITH HEPATIC COMA ACUTE ... OR UNSPECIFIED WITH HEPATIT 07022 VIRAL HEAPTITIS B. World J (Hepatitis C ...

Gastroenterology
... Clinicopathological study of viral heaptitis, A. Malik IA, Muzaffar M & Aftab ...

Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B (PDF)
www.wjgnet.com ... type chronic viral heaptitis B.World J Gastroenterol 2002;8 ...

Blogger: Email Post to a Friend
... interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai ... Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

Interferon - What is Hepatitis C?(NC)-Hepatitis C is an infectious

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - gihealth.com - built for patient satisfaction

gihealth.com - built for patient satisfaction
Interferon Therapy ... What Is Interferon? Interferon is a natural substance produced by your body in response to a viral infection ... In this way, Interferon helps you recover from viral infections ...

Interferon - Wikipedia, the free encyclopedia
Interferon. From Wikipedia, the free encyclopedia. Interferons (IFNs) are natural proteins produced by the cells of the immune systems of most animals in response to challenges by foreign agents such as viruses, bacteria, parasites and tumor cells. ... the effects of interferon-alpha and interferon-beta. However, interferon-gamma must ...

Hemispherx Biopharma, Inc. -- Products -- ALFERON N Package Insert
... ALFERON N Injection [Interferon alfa-n3 (human leukocyte derived)] is a sterile aqueous formulation of purified, natural, human interferon alpha proteins for use by injection ...

Interferon
Dr Margaret Hunt. INTERFERON. Interferon response to an acute virus infection. Interferons play an important role in the first line of defense against viral infections. ... Interferon-a (a family of about 20 related proteins) and interferon-b are particularly potent as ...

HEPATITIS C TREATMENT / INTERFERON
HEPATITIS C VIRUS & LIVER DISEASE TREATMENT. LIVER DISEASE REMEDY & INFO ABOUT INTERFERON SIDE EFFECTS ... Since interferon was first introduced as a therapy for chronic non-A, non-B hepatitis in 1986, almost all patients using interferon and its combinations (i.e ...

Considering Peg Intron and Interferon?
... ::: Considering Peg Intron and Interferon. As most of you know, I have been trying for years to ... and the real reason the drug manufacturer altered Interferon to create it ...

Interferon - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - SciClone Announces Settlement of Schering Plough KK (SPKK) Dispute

SciClone Announces Settlement of Schering Plough KK (SPKK) Dispute
Market Wire - SAN MATEO, CA -- (MARKET WIRE) -- 04/03/2006 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN ) today announced that it has reached a settlement in its dispute with SPKK concerning clinical trials conducted in Japan with ZADAXIN , SciClone's lead

Relative risks of cirrhosis from non-alcoholic steatohepatitis
EurekAlert - Morbidity and mortality lower than for Hepatitis C, but still notable Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients

Infectious diseases rise
Canton Repository - CANTON - A childhood disease and a sexually transmitted disease accounted for the biggest share of the increase in infectious diseases in Stark County last year. Cases of pertussis, also known as whooping cough, more than tripled, from 17 in 2004 to

Oklahoma State House Panel Passes Tattoo Regulation Measure
Hometown Channel - OKLAHOMA CITY -- A state House panel passed legislation Monday that would license and regulate tattoo artists and parlors in Oklahoma, the only state in the nation that bans the body art. In a 15-7 vote, the House Health and Human Services Committee

Biotechs in region lead US in red ink
Boston Globe - New England's vaunted biotechnology industry leads the nation in just one thing: losing money. The region's publicly traded biotechnology companies lost nearly $1.2 billion in 2005, more than those in any other part of the country, according to a

By ROBIN ERB
Toledo Blade - DETROIT - The voice of an Adrian teenager - who four years ago was raped, held captive, and forced to prostitute herself - filled a still federal courtroom in Detroit yesterday shortly before the man convicted as her captor and pimp was sentenced to

Knockin' Down Threes
Motley Fool - The three-point shot can be a game-changer. If a team gets hot behind the arc, watch out. The points will start adding up fast. The power of the three-pointer This year's finalists, UCLA and Florida, are evenly matched teams. That's why their

Hepatitis C - Human Genome Sciences: challenging the pegylated interferons

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - Mar 15 8:51 PM
Interim results of a phase II trial of Human Genome Sciences Albuferon in combination with ribavirin showed a significant antiviral effect in non-responders at 48 weeks of treatment. Although its favorable once-monthly dosing puts Albuferon in a strong position to potentially replace pegylated interferon, the drugs success might be delayed by the approval of specific HCV inhibitors.Save to My Web

Peregrine Pharmaceuticals Files Shelf Registration Statement
[Press Release] PR Newswire via Yahoo! Finance - Mar 31 9:13 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission which, when declared effective by the SEC, will allow Peregrine from time to time to offer and sell up to fifteen Save to My Web

Achillion Pharmaceuticals files for IPO
BizJournals - Apr 03 8:23 AM
Achillion Pharmaceuticals Inc. of New Haven, Conn., has filed a registration statement on Form S-1 with the Securities and Exchange Commission for the proposed initial public offering of shares of its common stock. All shares of the common stock in the offering would be sold by Achillion.Save to My Web

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2005
FinanzNachrichten - Mar 20 11:08 AM
NEW YORK, March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals, ( Nachrichten ) Ltd. , a biotechnology company focused on the acquisition, development and commercialization of therapeutics for the treatment of infectious diseases, with a focus on hepatitis C, today announced its financial results for year ended December 31, 2005.Save to My Web

Human Genome Sciences: Challenging the Pegylated Interferons
RedNova - Mar 15 11:32 AM
Interim results of a phase II trial of Human Genome Sciences' Albuferon in combination with ribavirin showed a significant antiviral effect in non-responders at 48 weeks of treatment.Save to My Web

Coley Pharmaceutical Group Announces Top-line Data from a Clinical Study of Actilon(TM) for Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Mar 21 5:30 AM
Coley Pharmaceutical Group, Inc. today announced positive top-line interim data from the company's twelve-week, randomized, controlled clinical study of Actilon in combinations with pegylated interferon and/or ribavirin for the treatment of chronic Hepatitis C virus in the relapsed subset of treatment experienced patients.Save to My Web

Interferon - Is drug resistance a good thing?

Is drug resistance a good thing?
Gay.com UK - A US scientist has found that drug-resistant HIV stimulates the immune system less strongly. This is good news, not bad - because the main reason people develop AIDS is because the constant fight against HIV exhausts the immune system. Dr Steven

Enzyme inhibitors block replication of SARS virus
EurekAlert - The study was conducted by researchers from Scripps Research; the Genomics Research Center, Academia Sinica, Taiwan; and the National Taiwan University. It is being published today in the journal Chemistry and Biology (Vol. 13, No. 3). Chi-Huey Wong

AIDS: viral fitness explains different resistance patterns to drugs
Xagena Medical News - Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. For other medications, resistance occurs only when patients take most of their pills. These differences appear to be

Hepatitis C Market: Plenty Of Potential, But Little Progress
Investors Business Daily - The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a global epidemic by the World Health Organization. On March 21, Valeant Pharmaceuticals ( VRX

Activists: Hepatitis C clinical trial unfairly excludes blacks
Advocate - Two advocacy groups are blasting the decision by pharmaceutical company Schering-Plough to exclude African-Americans from a clinical trial of its experimental hepatitis C treatment, a decision the company says was needed to better gauge the efficacy

Procyon Announces the Completion of the Acquisition of Cellpep S.A.
Money Plans - Procyon Biopharma Inc. is pleased to announce that it has completed today the closing of the acquisition of Cellpep S.A. and the concurrent private placement of $18.1 million under the terms previously announced on January 19, 2006. Concurrently

Interferon - Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C

Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Mar 23 2:01 PM
Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases, announced today an update on its clinical development program for valopicitabine for the treatment of hepatitis C.Save to My Web

Carol G. Gallagher, Pharm. D., To Join Anadys Pharmaceuticals As Vice President, Commercial Affairs
RedNova - Mar 22 7:30 AM
SAN DIEGO, March 22 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. announced today the hiring of Carol G. Gallagher, Pharm. D., as Vice President, Commercial Affairs. Dr.Save to My Web

4th Monico cup drawing of lots scheduled today
Sun Star - Mar 17 8:57 PM
THE bracketing of teams in both the 19-Under and 26-Under divisions of the 4th Monico Cup Inter-Barangay Summer Basketball tournament goes on Saturday as scheduled, 2 p.m. at the residence of Bacolod City Representative Monico 0. Puentevella.Save to My Web

ViroPharma Announces Positive Phase 2 Results Demonstrating That Maribavir Significantly Reduces CMV Reactivation
FinanzNachrichten - Mar 29 5:22 PM
EXTON, Pa., March 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated ( Nachrichten ) today announced positive preliminary results from a Phase 2 study with maribavir, an oral antiviral drug candidate currently being developed to inhibit cytomegalovirus (CMV) reactivation in transplant patients.Save to My Web

ViroPharma Further Comments on Vancocin
Boursorama - Mar 17 1:12 PM
EXTON, Pa., March 17 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today filed a Petition for Stay of Action with the FDA regarding the requirements for waivers of in-vivo bioequivalence testing for Vancocin.Save to My Web

Pharmaceutical and Biotechnology Companies Are Increasingly Shifting Their Drug Development for Infectious Diseases
[Press Release] Business Wire via Yahoo! Finance - Mar 23 4:05 AM
DUBLIN, Ireland----March 23, 2006--Research and Markets has announced the addition of the Decision Resources report "Emerging Antiviral Drug Targets" to their offeringSave to My Web

Morgan & Finnegan is First Intellectual Property Firm to Open a Shanghai Office
[Press Release] Business Wire via Yahoo! Finance - Mar 16 6:00 AM
NEW YORK----March 16, 2006--Morgan & Finnegan, L.L.P., one of the oldest and most successful intellectual property law firms, has opened an office in Shanghai, China. The office is staffed by two partners, Maria C.H.Save to My Web